COMPOSITIONS AND USES THEREOF FOR IDENTIFYING AND TARGETING PROVASOPRESSIN-EXPRESSING CANCER CELLS

Details for Australian Patent Application No. 2003251966 (hide)

Event Publications

16 October 2003 Complete Application Filed

Priority application(s): 60/396,121 16.07.02 US

18 March 2004 Application Open to Public Inspection

Published as AU-A-2003251966

2 June 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 27 Apr 2005

1 September 2005 Section 223 Application Received

Woomera Therapeutics, Inc. An application to extend the time from 01 Feb 2005 to 01 Jun 2005 in which to comply with Section 6(c) has been filed . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

27 October 2005 Section 223 Application Allowed

Woomera Therapeutics, Inc. The time in which to comply with Section 6(c) has been extended to 01 Jun 2005. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.